Dr. Daniel Andrew Sussman, MD

Dr. Sussman practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Sussman's NPI, 1316148869, was assigned on May 31, 2007. Dr. Sussman graduated from University of Miami, Miller School of Medicine in 2002. Dr. Sussman holds Florida license ME0101269.

Dr. Sussman's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Sussman's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Sussman is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sussman practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Sussman's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Sussman is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Sussman is licensed in Florida.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastroduodenitis, gastroenteritis, gastrointestinal bleeding, hemorrhoids and inflammatory bowel disease (IBD) among the conditions Dr. Sussman treats.

CMS data shows 307 Medicare services from Dr. Sussman across 8 procedure codes in 2024, for 234 Medicare patients. Medicare paid $27,337 for them.

CMS counts 234 Medicare patients who saw Dr. Sussman in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 29% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sussman's median patient age at 68, with 58% women.

In 2024, Dr. Sussman wrote 306 Medicare Part D claims for 137 patients. 76% of them were for generic drugs. CMS names the drug for 187 of them, across 8 drugs with 11 or more claims each, at $5,538 in total drug cost. In 2023, CMS named 231 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Sussman for performance year 2024, reported as part of a group. Dr. Sussman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sussman as offering telehealth. CMS counts 55 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Sussman, more than 65% of the clinicians it reports for that procedure.

Dmand AI links 94 papers to Dr. Sussman, published from 2008 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Colorectal Neoplasms, Early Detection of Cancer and Florida. Dr. Sussman has published most often in Dig Dis Sci. Dr. Sussman's most frequent co-authors are Amar R. Deshpande, MD, Maria Teresa Abreu, MD and Jamie S. Barkin, MD.

Dmand AI links Dr. Sussman to 1 clinical trial. Conditions studied include Inflammatory Bowel Diseases and Gastroenteritis.

CMS Open Payments shows 7 general payments to Dr. Sussman from 6 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 98% of the total. Janssen Research & Development, LLC paid the most, $4,545.

Dmand AI lists 1 award for Dr. Sussman, most recently CMS Stage 1 EHR in 2014.

Dr. Sussman graduated from University of Miami, Miller School of Medicine in 2002.

Dr. Sussman is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.